Media Coverage & Press Release
MAY 2025
Press Release
Senores Pharmaceuticals acquires ANDA for Enalapril Maleate Tablets 2.5mg, 5mg, 10mg and 20mg from WockhardtFinancial & Operational Performance for Q4 & FY25
Senores Pharmaceuticals acquires ANDA for Tramadol Tablets from APDM Pharmaceuticals
Senores Pharmaceuticals acquires ANDA for Topiramate HCl 25, 50, 100 and 200 mg tablets
APR 2025
Media Coverage
India's Senores Pharma Better Placed on US Tariff Impact (Source: Bloomberg)MAR 2025
Press Release
Senores Pharmaceuticals acquires 14 ANDAs from Dr. Reddy’s LaboratoriesFEB 2025
Press Release
Senores Pharmaceuticals begins operations at greenfield API facilitySenores Pharmaceuticals acquires ANDA for Roflumilast 250 mcg and 500 mcg
JAN 2025
Press Release
Financial & Operational Performance for Q3 & 9MFY25Senores Pharmaceuticals receives ANDA approval for marketing Metoprolol Tartrate and Hydrochlorothiazide Tablet
NOV 2024
Media Coverage
Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. launches Ivermectin Tablets in the U.S. market (Source: Nasdaq)Dr. Reddy's Laboratories and Senores Pharmaceuticals, Inc. launches Ivermectin Tablets in the U.S. market (Source: Financial Times)